Transcriptomics

Dataset Information

0

Extracellular vesicle microRNA profiling in synovial fluids and plasma from Oligoarticular Juvenile Idiopathic Arthritis patients: methodological challenges and identification of putative disease biomarkers


ABSTRACT: New early low-invasive biomarkers are demanded for the management of Oligoarticular Juvenile Idiopathic Arthritis (OJIA), the most common chronic inflammatory arthritis in childhood and a leading cause of disability. Extracellular vesicles (EVs) released in the synovial fluid (SF) of inflamed joints have gained increased recognition as mediators of arthritis pathogenesis and as a source of biomarkers. No standardized protocol is available, yet, for the analysis of EV-derived microRNAs (EV-miRs) in human SF specimens, and their potential as biomarkers in OJIA has not been explored. This study proposes an optimized procedure for profiling EV-miRs in SF and represents the first investigation of the miRNome in EV isolated from OJIA patients at disease onset. We present data showing efficient recovery of EVs from SF aspirates and optimal profiling of their miRNA content. We identified a subset of 15 EV-miRs whose expression was deregulated in SF. Analysis of EV-miRs target genes evidenced the enrichemnt of processes related to inflammation, cartilage/bone homeostasis, hypoxia, and hormone metabolism, suggesting their contribution to disease pathogenesis and potential as new putative biomarkers. In addition, we detected altered expression levels of several circulating EV-miRs able to discriminate new-onset OJIA patients from control children. Among them, 16 were consensually overexpressed in both PL and SF from OJIA patients respect to controls, potentially representing a disease-associated molecular “fingerprint” measurable at both the systemic and local levels with high diagnostic potential. These results improve our understanding of OJIA molecular mechanisms and provide an important contribution in the search of new candidate biomarkers for early OJIA diagnosis and the design of novel tailored therapies.

ORGANISM(S): Homo sapiens

PROVIDER: GSE191326 | GEO | 2022/12/30

REPOSITORIES: GEO

Similar Datasets

2023-07-05 | PXD039166 | Pride
2021-04-01 | PXD015145 | Pride
2022-12-28 | GSE193482 | GEO
2022-09-28 | GSE203157 | GEO
2009-03-04 | GSE15083 | GEO
2022-09-14 | GSE188627 | GEO
2009-03-04 | E-GEOD-15083 | biostudies-arrayexpress
2013-06-19 | E-GEOD-47897 | biostudies-arrayexpress
2022-08-31 | GSE200330 | GEO
2015-04-07 | GSE67596 | GEO